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Lesson of the week
Raised cortisol excretion rate in urine and contamination
by topical steroids
Christopher J G Kelly, Arla Ogilvie, John R Evans, David Shapiro, A Michael Wallace, David L Davies
The clinical features of type 2 diabetes (obesity, hyper›
tension, and glycosuria) often overlap with those of
Cushing’s syndrome, and as impaired glucose toler›
ance occurs in up to 20% of patients with Cushing’s
syndrome, its incidence in people with diabetes is
higher than among people without diabetes.1 Diagno›
sis relies on clinical suspicion and abnormal results of
biochemical tests. Measurement of the excretion rate of
free cortisol in the urine forms the basis of the initial
outpatient investigations and should reflect the overall
cortisol secretion provided it is measured accurately.
We present two cases from diabetic clinics in which
patients had raised urinary free cortisol excretion rates
as a result of urinary contamination by vaginal cream
containing hydrocortisone.
Case reports
Case 1—A 49 year old woman with type 2 diabetes
mellitus, hypertension, and depression was referred for
investigation of possible Cushing’s syndrome. The his›
tory was of deteriorating control of glycaemia and
blood pressure. Outpatient measurement of overnight
urinary cortisol:creatinine ratios showed grossly raised
values (mean 255 ìmol cortisol/mol creatinine; range
15›1191; normal < 25 ìmol/mol creatinine). She was
admitted and underwent a series of complex tests to
define her Cushing’s syndrome, all of which yielded
normal results. Despite this, the urinary free cortisol
excretion rate remained high (4365 nmol/24 hour;
normal rate < 250 nmol/24 hour). This pattern
strongly suggested the presence of a factor interfering
in the measurement of urinary free cortisol, which we
confirmed using gas chromatography. This showed
excipients consistent with the use of topical steroid
cream. Further questioning of the patient revealed that
she had been using an antifungal cream containing
hydrocortisone (Canesten HC, Baypharm, Bayer,
Berks) for vaginal candidiasis. Once this was stopped,
urinary free cortisol excretion rates returned to normal
(120 nmol/24 hour).
Case 2—A 38 year old woman with type 2 diabetes,
gross obesity, and facial plethora also underwent inves›
tigations for Cushing’s syndrome. Overnight urinary
cortisol:creatinine ratios were again moderately raised
over a two month period (range 14 to 137 ìmol/mol
creatinine; normal < 25 ìmol/mol creatinine), but
serum cortisol concentrations were within reference
limits with a normal diurnal variation and a normal
result of an overnight dexamethasone suppression test.
Because of the similarity with case 1, the patient was
interviewed and also admitted using Canesten HC
cream on perineal and vaginal areas to treat candidia›
sis. After she discontinued this treatment, urinary corti›
sol:creatinine ratios returned to normal on all three
occasions tested (5, 11, and 11 ìmol/mol creatinine).
Discussion
In both patients contamination of their urine with
Canesten HC during collection was responsible for the
increased urinary cortisol values. This cream contains
1% hydrocortisone and a normal application is about
0.5 g. Direct contamination with as little as 0.035 mg of
cream (0.007% of that applied) would raise urinary free
cortisol concentration to above the normal range. Uri›
nary free cortisol measurements are often used as an
initial inexpensive screening test for patients with clini›
cal symptoms of Cushing’s syndrome. The pitfalls of
the test are many and include incomplete 24 hour col›
lection, solutes interfering with the competitive
binding assay, and the presence in the urine of admin›
istered steroids.2 3 Steroids are administered by numer›
ous routes, and the above cases show that before
investigations are conducted patients should be asked
if they are using any topical preparation, as drugs given
topically are often not considered a medication by the
patient and consequently not mentioned.
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